ResearchSafe

KLOW Stack (KLOW (GHK-Cu + KPV + BPC-157 + TB-500))

Category: Popular Stacks. Status: Research stack.

An advanced regenerative and anti-inflammatory peptide blend. KLOW combines four core peptides, GHK-Cu, KPV, BPC-157, and TB-500, to promote cellular repair, tissue regeneration, and healing. Frequently utilized in clinical and research protocols for post-surgery recovery, aesthetic enhancement, and metabolic optimization.

How it works

Multi-pathway regenerative approach: GHK-Cu activates collagen synthesis and attracts repair cells via copper peptide signaling. KPV inhibits NF-κB to reduce systemic inflammation. BPC-157 promotes angiogenesis and upregulates growth factor expression for tissue repair. TB-500 upregulates actin for cell migration and reduces inflammatory cytokines.

Key facts

  • Molecular weight: Multiple compounds
  • Half-life: Variable (2-6 hours depending on component)
  • Bioavailability: Variable by component and route
  • Storage: Lyophilized components: -20°C. Reconstituted: 2-8°C.

Dosing overview

  • Typical dose: GHK-Cu 200mcg + KPV 500mcg + BPC-157 500mcg + TB-500 2.5mg
  • Frequency: BPC-157 & KPV daily · TB-500 & GHK-Cu 2-3x/week
  • Duration: 8-12 weeks
  • Route: Subcutaneous injection

Protocol notes

  • BPC-157 500 mcg: subcutaneously every day, often split AM/PM or placed near the injury.
  • KPV 500 mcg: daily (oral or subcutaneous) for its anti-inflammatory action.
  • TB-500 2.5 mg: 2-3x weekly during a loading phase for deeper tissue repair.
  • GHK-Cu 200 mcg: 2-3x weekly (or daily topical) for skin/collagen and copper-driven remodeling.
  • Each compound is drawn and injected separately - don't pre-mix in one syringe.

Reported benefits

  • Accelerated tissue regeneration
  • Systemic inflammation reduction
  • Post-surgical recovery
  • Collagen remodeling & skin repair
  • Aesthetic enhancement
  • Metabolic optimization

Possible side effects

  • Mild injection site irritation
  • Initial healing response
  • Temporary fatigue
  • Mild flushing (GHK-Cu)

Research

  • GHK-Cu and tissue remodeling (2021): GHK-Cu demonstrated 70% increase in collagen synthesis and enhanced wound closure rates in regenerative protocols.
  • Multi-peptide regenerative stacks (2022): Combination of anti-inflammatory (KPV) + healing (BPC-157/TB-500) peptides showed 2.5x faster tissue repair vs monotherapy.

Compare KLOW Stack

Community discussions about KLOW Stack

Research and educational reference only. Not medical advice.